Michael A. Finan, M.D.
Abraham A. Mitchell Chair
Director, USA Mitchell Cancer Institute
Dr. Michael A. Finan joined MCI in 2005 after serving as chairman of the Cancer Committee at Ochsner Clinic Foundation in New Orleans. He was named interin director of MCI in 2014 and director in May 2015. Dr. Finan specializes in a variety of cancers affecting women including cervical, vaginal, endometrial, vulvar, fallopian tube and ovarian cancer, as well as gestational trophoblastic neoplasia. Dr. Finan was the first gynecologist in Mobile to perform robotic surgery with the DaVinci Robotic Surgery System, and is listed in the most recent Top Doctors directory issued by U.S. News and World Report.
Rodney P. Rocconi, M.D.
Chief, Gynecologic Oncology Service
Professor of Interdisciplinary Clinical Oncology
Dr. Rodney P. Rocconi joined MCI as a physician-scientist in the Gynecologic Oncology Service in 2007. He specializes in the management of cancers of the ovary, uterus, cervix and lower genital tract. As associate director for Clinical Research, Dr. Rocconi provides leadership and medical expertise to the clinical trials department, reviews and designs clinical research protocols, evaluates safety and efficacy data, analyzes and summarizes data for presentation to regulatory agencies, and provides strategic guidance on non-regulatory clinical trial plans. In 2016, he was chosen as one of 16 oncologists nationally for a leadership program of the American Society of Clinical Oncology, the world’s leading professional organization for physicians and oncology professionals caring for people with cancer.
Jennifer Scalici, M.D.
Gynecologic Oncologist, Physician Scientist
Associate Professor of Interdisciplinary Clinical Oncology
Dr. Jennifer Scalici received her medical degree from the University of Alabama School of Medicine, and completed an internship and residency at Northwestern University, McGaw Medical Center. While a fellow at the University of Virginia Health System, she served as primary investigator in a study involving advanced epithelial ovarian cancer at the University of Virginia Cancer Center. Dr. Scalici is a member of American Association of Cancer Research Associate Member, Society of Gynecologic Oncologists: Fellow in Training, and the American College of Obstetricians and Gynecologists: Jr. Fellow. She has a special research interest in ovarian cancer metastasis and platinum resistance, and has published papers and given numerous presentations on gynecologic oncology topics.
Nathaniel Jones, M.D.
Assistant Professor of Interdisciplinary Clinical Oncology
Dr. Nate Jones received his medical degree from East Tennessee State University Quillen College of Medicine and completed his residency training in obstetrics and gynecology at Mountain Area Health Education Center in Asheville, N.C. Prior to joining MCI in 2017, he completed his fellowship training in gynecologic oncology at New York Presbyterian Hospitals, a combined program through Columbia University College of Physicians and Surgeons and Weill Cornell Medical College. Dr. Jones is a member of the Society of Gynecologic Oncologists, the American Society of Clinical Oncology, the American College of Obstetricians and Gynecologists, and the American Association of Gynecologic Laparoscopists. His research interests include genetic and molecular characterization of uterine and ovarian cancers.
Dr. Luciana Madeira da Silva received her Ph.D. as a molecular microbiologist and is a Research Assistant Professor with the gynecologic oncology team at MCI. Dr. Madeira da Silva was selected to serve in the newly appointed position to oversee the research of the gynecologic oncology lab. Her research focuses on a cell surface glycoprotein that regulates metabolism and metastasis and its oncogenic properties in cancer. Dr. Madeira da Silva joined MCI in 2011 after completing postdoctoral research at Washington University School of Medicine in St. Louis, and after receiving her doctorate from the University of São Paulo in Brazil. Dr. Madeira da Silva has 15 years of laboratory experience in biochemistry, cellular and molecular biology, and has authored seven publications on a variety of topics. She is credited with two patents, in the United States and Brazil, for drug screening and treatment methods. She has presented at more than 17 medical seminars and conferences nationally and internationally and is an active community service participant.
Dr. Leigh A. Minchew has been with the University of South Alabama since 2007, and joined USA Mitchell Cancer Institute in 2013 as a Gynecologic Oncology Nurse Practitioner. She is a board-certified women's health nurse practitioner and completed her Doctor of Nursing Practice at Case Western Reserve University in Cleveland, Ohio in 2010. She is a faculty member with the USA College of Nursing and coordinates the WHNP Specialty Option for MSN and DNP programs. Dr. Minchew is a member of several national nursing associations including the Society of Gynecologic Nurse Oncologists (SGNO). She also has active roles in the Alabama Office of Women's Health and Alabama State Nurses Association.
Impacted by the loss of her mother in 2006 to ovarian/primary peritoneal cancer, Dr. Minchew has tremendous empathy for individuals and families impacted by women's cancers, and she assists our physicians in providing palliative care and participates in research. As a part of the gynecologic oncology team, Dr. Minchew provides a program of survivorship where care is given seamlessly, during active treatment and post-treatment, providing resources to encourage living life to the fullest potential.
© 2017 USA Health System